Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09PSZ
|
|||
| Former ID |
DIB014861
|
|||
| Drug Name |
Deferitrin
|
|||
| Synonyms |
GT-56-252; Desferrithiocin analogs (iron overload), SunPharm/Schein; Iron chelators (iron overload), GelTex/Schein
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Iron overload disease [ICD-11: 5C64.10; ICD-10: E83.1, G23.0] | Phase 1/2 | [1] | |
| Company |
University of Florida
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H11NO4S
|
|||
| Canonical SMILES |
CC1(CSC(=N1)C2=C(C=C(C=C2)O)O)C(=O)O
|
|||
| InChI |
1S/C11H11NO4S/c1-11(10(15)16)5-17-9(12-11)7-3-2-6(13)4-8(7)14/h2-4,13-14H,5H2,1H3,(H,15,16)/t11-/m1/s1
|
|||
| InChIKey |
OEUUFNIKLCFNLN-LLVKDONJSA-N
|
|||
| CAS Number |
CAS 239101-33-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00069862) Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.